ILDSTAD SUZANNE (Chief Scientific Officer) sold 1.1% of their position (31.53K shares) of TOURMALINE BIO, INC. on the open market
Open‑market sale worth $79.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/5/2023ACC: 0001209191-23-034287
DirectorOfficer10% Owner· Chief Scientific Officer
Since May 2021
-31.53K
Net shares
Net seller
$79.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
31.53K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−15.71K
Price / share
$2.56
Trade value
$40.18K
% of position
0.6%
6/1/2023
2.82M→2.81M
Common Stock
Direct
Shares
−15.82K
Price / share
$2.50
Trade value
$39.62K
% of position
0.6%
6/2/2023
2.81M→2.79M
Total
Net shares
−31.53K
Net value
-$79.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2023 | S · Sale | −15.71K | $2.56 | $40.18K | 0.6% | 2.82M | 2.81M |
| Common Stock Direct | 6/2/2023 | S · Sale | −15.82K | $2.50 | $39.62K | 0.6% | 2.81M | 2.79M |
| Total | −31.53K | -$79.79K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned1.20M
Total
2.51M indirect2.51M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 654.21K | Indirect |
| Common Stock | 654.21K | Indirect |
| Common Stock | 1.20M | Indirect |
| Total | 2.51M | 2.51M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported